University of Texas Health Science Center at San Antonio

New target isolated for leukemia drug development

There are potentially effective treatments for acute myeloid leukemia (AML), but they only work in 20 to 40 percent of cases. In a paper published today in Leukemia, a Nature journal, a UT Health Science Center researcher has pi ...

Feb 11, 2014
popularity not rated yet | comments 0 | with audio podcast

New hope for taming triple-negative breast cancer

Disease-free survival is short-lived for women with triple-negative breast cancer—a form of the disease that doesn't respond to hormone drugs and becomes resistant to chemotherapy. Thankfully, a promising ...

Oct 02, 2012
popularity 4.3 / 5 (3) | comments 0